Cigna Group 8-K Filing Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Cigna Corporation on December 8, 2020. The filing discloses executive officer appointments effective January 1, 2021, and details the associated compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on personnel changes and compensation terms.
Material Changes
The primary material change reported is the appointment of three new executive officers effective January 1, 2021:
- Eric P. Palmer: Appointed President and Chief Operating Officer of Evernorth.
- Brian C. Evanko: Appointed Executive Vice President and Chief Financial Officer of Cigna.
- Matthew G. Manders: Appointed President, Government and Solutions, Cigna.
Compensation and Management Commentary
In connection with these appointments, the executives accepted offer letters with the following material terms for Fiscal Year 2021:
| Executive | Base Salary | Enterprise Incentive Plan (Annual Target) | Long-term Incentive (Annual Target) |
|---|---|---|---|
| Eric P. Palmer | $950,000 | $950,000 | $4,300,000 |
| Brian C. Evanko | $800,000 | $900,000 | $2,800,000 |
| Matthew G. Manders | $1,000,000 | $1,250,000 | $4,250,000 |
The filing states that these executives are eligible to participate in the Company's employee benefit plans in accordance with their terms. No specific guidance, outlook, risks, or contingencies regarding financial performance are disclosed in this report.
Key Facts for Investor Verification
- Verify the effective date of the new executive appointments (January 1, 2021).
- Confirm the total potential annual compensation targets for the new CFO and Evernorth leadership.
- Review subsequent filings for any changes to the executive team or compensation structures.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.